Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12-6.11 (-2.22%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly R&D expense is $3.65 Billion with a quarter-over-quarter change of +3.57%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Reported quarterly R&D expense; no daily interpolation.
$3.65B
$3.65 Billion
+3.57%
vs. $3.53B prior quarter
96
Quarters of data available
| Period | R&D Expense | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $3.65B | +$126.00M | +3.57% |
| Quarter ended Mar 2026 | $3.53B | −$725.00M | -17.05% |
| Quarter ended Dec 2025 | $4.25B | +$580.00M | +15.80% |
| Quarter ended Sep 2025 | $3.67B | +$156.00M | +4.44% |
| Quarter ended Jun 2025 | $3.52B | +$291.00M | +9.02% |
| Quarter ended Mar 2025 | $3.23B | −$2.07B | -39.13% |
| Quarter ended Dec 2024 | $5.30B | +$346.00M | +6.99% |
| Quarter ended Sep 2024 | $4.95B | +$1.51B | +43.95% |
| Quarter ended Jun 2024 | $3.44B | −$102.00M | -2.88% |
| Quarter ended Mar 2024 | $3.54B | −$938.00M | -20.94% |
| Quarter ended Dec 2023 | $4.48B | +$1.03B | +29.97% |
| Quarter ended Oct 2023 | $3.45B | −$256.00M | -6.91% |
| Quarter ended Jul 2023 | $3.70B | +$248.00M | +7.18% |
| Quarter ended Apr 2023 | $3.46B | −$1.17B | -25.28% |
| Quarter ended Dec 2022 | $4.62B | +$1.14B | +32.68% |
| Quarter ended Oct 2022 | $3.48B | −$218.00M | -5.89% |
| Quarter ended Jul 2022 | $3.70B | −$369.00M | -9.06% |
| Quarter ended Apr 2022 | $4.07B | −$648.00M | -13.73% |
| Quarter ended Dec 2021 | $4.72B | +$1.30B | +37.93% |
| Quarter ended Oct 2021 | $3.42B | +$28.00M | +0.82% |
| Quarter ended Jul 2021 | $3.39B | +$216.00M | +6.80% |
| Quarter ended Apr 2021 | $3.18B | −$854.00M | -21.18% |
| Quarter ended Dec 2020 | $4.03B | +$1.19B | +41.97% |
| Quarter ended Sep 2020 | $2.84B | +$133.00M | +4.91% |
| Quarter ended Jun 2020 | $2.71B | +$127.00M | +4.92% |
| Quarter ended Mar 2020 | $2.58B | −$652.00M | -20.17% |
| Quarter ended Dec 2019 | $3.23B | +$633.00M | +24.36% |
| Quarter ended Sep 2019 | $2.60B | −$67.00M | -2.51% |
| Quarter ended Jun 2019 | $2.67B | −$192.00M | -6.72% |
| Quarter ended Mar 2019 | $2.86B | −$366.00M | -11.35% |
| Quarter ended Dec 2018 | $3.22B | +$716.00M | +28.55% |
| Quarter ended Sep 2018 | $2.51B | −$131.00M | -4.96% |
| Quarter ended Jul 2018 | $2.64B | +$235.00M | +9.78% |
| Quarter ended Apr 2018 | $2.40B | −$1.23B | -33.87% |
| Quarter ended Dec 2017 | $3.63B | +$1.05B | +40.62% |
| Quarter ended Oct 2017 | $2.58B | +$289.00M | +12.59% |
| Quarter ended Jul 2017 | $2.30B | +$226.00M | +10.92% |
| Quarter ended Apr 2017 | $2.07B | −$570.00M | -21.59% |
| Quarter ended Dec 2016 | $2.64B | +$462.00M | +21.21% |
| Quarter ended Oct 2016 | $2.18B | −$86.00M | -3.80% |
| Quarter ended Jul 2016 | $2.26B | +$251.00M | +12.47% |
| Quarter ended Apr 2016 | $2.01B | −$851.00M | -29.71% |
| Quarter ended Dec 2015 | $2.86B | +$710.00M | +32.96% |
| Quarter ended Sep 2015 | $2.15B | +$25.00M | +1.17% |
| Quarter ended Jun 2015 | $2.13B | +$230.00M | +12.11% |
| Quarter ended Mar 2015 | $1.90B | −$736.00M | -27.93% |
| Quarter ended Dec 2014 | $2.63B | +$612.00M | +30.25% |
| Quarter ended Sep 2014 | $2.02B | +$18.00M | +0.90% |
| Quarter ended Jun 2014 | $2.00B | +$174.00M | +9.50% |
| Quarter ended Mar 2014 | $1.83B | −$580.00M | -24.06% |
| Quarter ended Dec 2013 | $2.41B | +$369.00M | +18.07% |
| Quarter ended Sep 2013 | $2.04B | +$96.00M | +4.93% |
| Quarter ended Jun 2013 | $1.95B | +$162.00M | +9.08% |
| Quarter ended Mar 2013 | $1.78B | −$547.00M | -23.47% |
| Quarter ended Dec 2012 | $2.33B | +$408.00M | +21.22% |
| Quarter ended Sep 2012 | $1.92B | +$157.00M | +8.89% |
| Quarter ended Jul 2012 | $1.77B | +$121.00M | +7.36% |
| Quarter ended Apr 2012 | $1.65B | −$510.00M | -23.67% |
| Quarter ended Dec 2011 | $2.15B | +$382.00M | +21.55% |
| Quarter ended Oct 2011 | $1.77B | −$109.00M | -5.79% |
| Quarter ended Jul 2011 | $1.88B | +$144.00M | +8.29% |
| Quarter ended Apr 2011 | $1.74B | −$244.00M | -12.31% |
| Quarter ended Dec 2010 | $1.98B | +$325.00M | +19.61% |
| Quarter ended Oct 2010 | $1.66B | +$9.00M | +0.55% |
| Quarter ended Jul 2010 | $1.65B | +$91.00M | +5.84% |
| Quarter ended Apr 2010 | $1.56B | −$656.00M | -29.64% |
| Quarter ended Dec 2009 | $2.21B | +$596.00M | +36.86% |
| Quarter ended Sep 2009 | $1.62B | −$21.00M | -1.28% |
| Quarter ended Jun 2009 | $1.64B | +$120.00M | +7.91% |
| Quarter ended Mar 2009 | $1.52B | −$590.00M | -27.99% |
| Quarter ended Dec 2008 | $2.11B | +$247.00M | +13.27% |
| Quarter ended Sep 2008 | $1.86B | −$75.00M | -3.87% |
| Quarter ended Jun 2008 | $1.94B | +$224.00M | +13.08% |
| Quarter ended Mar 2008 | $1.71B | −$616.00M | -26.46% |
| Quarter ended Dec 2007 | $2.33B | +$494.00M | +26.94% |
| Quarter ended Sep 2007 | $1.83B | −$32.00M | -1.71% |
| Quarter ended Jul 2007 | $1.87B | +$214.00M | +12.95% |
| Quarter ended Apr 2007 | $1.65B | −$394.00M | -19.26% |
| Quarter ended Dec 2006 | $2.05B | +$327.00M | +19.02% |
| Quarter ended Oct 2006 | $1.72B | −$109.00M | -5.96% |
| Quarter ended Jul 2006 | $1.83B | +$296.00M | +19.32% |
| Quarter ended Apr 2006 | $1.53B | −$444.00M | -22.47% |
| Quarter ended Dec 2005 | $1.98B | +$437.00M | +28.40% |
| Quarter ended Oct 2005 | $1.54B | +$14.00M | +0.92% |
| Quarter ended Jul 2005 | $1.52B | +$141.00M | +10.19% |
| Quarter ended Apr 2005 | $1.38B | −$343.00M | -19.86% |
| Quarter ended Dec 2004 | $1.73B | +$529.00M | +44.16% |
| Quarter ended Sep 2004 | $1.20B | +$16.00M | +1.35% |
| Quarter ended Jun 2004 | $1.18B | +$87.00M | +7.95% |
| Quarter ended Mar 2004 | $1.09B | −$394.00M | -26.46% |
| Quarter ended Dec 2003 | $1.49B | +$312.00M | +26.51% |
| Quarter ended Sep 2003 | $1.18B | +$95.00M | +8.78% |
| Quarter ended Jun 2003 | $1.08B | +$146.00M | +15.60% |
| Quarter ended Mar 2003 | $936.00M | −$306.00M | -24.64% |
| Quarter ended Dec 2002 | $1.24B | +$290.00M | +30.46% |
| Quarter ended Sep 2002 | $952.00M | N/A | N/A |